PURPOSE: The purpose of the present study is to investigate whether hemodialysis (HD) is effective in lowering blood glutamate levels. In addition, we examined the effect of HD on glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in the blood and described the rate and pattern of blood glutamate clearance during HD. MATERIALS AND METHODS: Blood samples were taken from 45 patients with stage V chronic kidney disease immediately after initiation of HD and hourly, for a total of 5 blood samples. Samples were sent for determination of glutamate, glucose, GOT, GPT, hemoglobin, hematocrit, urea, and creatinine levels. A blood sample from 25 healthy volunteers without chronic renal failure was used as a control for the determination of baseline blood levels of glutamate, GOT, and GPT. RESULTS: Glutamate and GPT levels in patients on HD were higher at baseline compared with healthy controls (P < .001). In the first 3 hours after HD, there was a decrease in blood glutamate levels compared with baseline levels (P < .00001). At the fourth hour, there was an increase in blood glutamate levels compared with the third hour (P < .05). CONCLUSIONS: Hemodialysis may be a promising method of reducing blood glutamate levels.
PURPOSE: The purpose of the present study is to investigate whether hemodialysis (HD) is effective in lowering blood glutamate levels. In addition, we examined the effect of HD on glutamate oxaloacetate transaminase (GOT) and glutamate pyruvate transaminase (GPT) levels in the blood and described the rate and pattern of blood glutamate clearance during HD. MATERIALS AND METHODS: Blood samples were taken from 45 patients with stage V chronic kidney disease immediately after initiation of HD and hourly, for a total of 5 blood samples. Samples were sent for determination of glutamate, glucose, GOT, GPT, hemoglobin, hematocrit, urea, and creatinine levels. A blood sample from 25 healthy volunteers without chronic renal failure was used as a control for the determination of baseline blood levels of glutamate, GOT, and GPT. RESULTS:Glutamate and GPT levels in patients on HD were higher at baseline compared with healthy controls (P < .001). In the first 3 hours after HD, there was a decrease in blood glutamate levels compared with baseline levels (P < .00001). At the fourth hour, there was an increase in blood glutamate levels compared with the third hour (P < .05). CONCLUSIONS: Hemodialysis may be a promising method of reducing blood glutamate levels.
Authors: Fatina I Fadel; Manal F Elshamaa; Rascha G Essam; Eman A Elghoroury; Gamila S M El-Saeed; Safinaz E El-Toukhy; Mona Hamed Ibrahim Journal: Int J Biomed Sci Date: 2014-03
Authors: Evgeni Brotfain; Ruslan Kutz; Julia Grinshpun; Benjamin F Gruenbaum; Shaun E Gruenbaum; Amit Frenkel; Agzam Zhumadilov; Vladimir Zeldetz; Yoav Bichovsky; Matthew Boyko; Moti Klein; Alexander Zlotnik Journal: Neurotox Res Date: 2017-08-23 Impact factor: 3.911
Authors: Matthew Boyko; Shaun E Gruenbaum; Benjamin F Gruenbaum; Yoram Shapira; Alexander Zlotnik Journal: J Neural Transm (Vienna) Date: 2014-03-13 Impact factor: 3.575
Authors: José Castillo; María Isabel Loza; David Mirelman; José Brea; Miguel Blanco; Tomás Sobrino; Francisco Campos Journal: J Cereb Blood Flow Metab Date: 2015-10-02 Impact factor: 6.200